Home Other Building Blocks 1802148-05-5
1802148-05-5,MFCD31619232
Catalog No.:AA01EODT

1802148-05-5 | AZD7986

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$123.00   $86.00
- +
5mg
>98% (or refer to the Certificate of Analysis)
in stock  
$218.00   $153.00
- +
50mg
98%
in stock  
$335.00   $234.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA01EODT
Chemical Name:
AZD7986
CAS Number:
1802148-05-5
Molecular Formula:
C23H24N4O4
Molecular Weight:
420.4611
MDL Number:
MFCD31619232
SMILES:
N#C[C@H](Cc1ccc(cc1)c1ccc2c(c1)n(C)c(=O)o2)NC(=O)[C@@H]1CNCCCO1
Properties
Computed Properties
 
Complexity:
699  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
5  
XLogP3:
2  

Downstream Synthesis Route

[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[2]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[3]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[4]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[5]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[6]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[7]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[8]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[9]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[10]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[11]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[12]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[13]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[14]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[15]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[16]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[2]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[3]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[4]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[5]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[6]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[7]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[8]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[2]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[3]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[4]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1Locationinpatent:Paragraph0409-0411

[2]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2Locationinpatent:Page/Pagecolumn52

[3]Doyle,Kevin;Lönn,Hans;Käck,Helena;VanDePoël,Amanda;Swallow,Steve;Gardiner,Philip;Connolly,Stephen;Root,James;Wikell,Cecilia;Dahl,Göran;Stenvall,Kristina;Johannesson,Petra[JournalofMedicinalChemistry,2016,vol.59,#20,p.9457-9472]

[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[2]CurrentPatentAssignee:ASTRAZENECAPLC-US2015/210655,2015,A1

[3]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

[4]CurrentPatentAssignee:ASTRAZENECAPLC-US9522894,2016,B2

Literature

Title: Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986).

Journal: Journal of medicinal chemistry 20161027

Title: Doyle K, et al. Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986). J Med Chem. 2016 Oct 27;59(20):9457-9472.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1802148-05-5
Tags:1802148-05-5 Molecular Formula|1802148-05-5 MDL|1802148-05-5 SMILES|1802148-05-5 AZD7986